Early kinetics of serum amyloid A predict clinical benefit to first-line chemoimmunotherapy and immunotherapy in advanced non-small cell lung cancer: a retrospective analysis by Wei Du, Jianhua Zhan, Kai Wu, Yanming Wang, Li Zhang, Shaodong Hong

Get full text

Comparative analysis of first-generation epidermal growth factor receptor inhibitors combined with chemotherapy versus third-generation epidermal growth factor receptor inhibitors... by Siyan Peng, Siyan Peng, Zhixin Yu, Zhixin Yu, Honglin Zhu, Honglin Zhu, Chuwen Liang, Chuwen Liang, Huijuan Qiu, Huijuan Qiu, Shaodong Hong, Shaodong Hong, Yixin Zhou, Yixin Zhou

Get full text

Efficacy and safety of immune checkpoint inhibitors in the treatment of recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis by Zhixin Yu, Shaodong Hong, Hui Yu, Xuanye Zhang, Zichun Li, Ping Chen, Yixin Zhou, Jing Ni

Get full text

Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors by Zihong Chen, Gang Chen, Yuxiang Ma, Hongyun Zhao, Jianhua Zhan, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Shaodong Hong, Ting Zhou, Wenfeng Fang, Li Zhang, Yaxiong Zhang

Get full text

Phase 1b/2 study of ADG106, a 4-1BB/CD137 agonist, in combination with toripalimab in patients with advanced solid tumors by Shaoyan Lin, Yuxiang Ma, Yongsheng Wang, Yunpeng Yang, Jinhui Xue, Yan Huang, Yuanyuan Zhao, Wenfeng Fang, Shaodong Hong, Yang Zhang, Qianwen Liu, Guizhong Liu, Xiaohong She, Jiping Zha, Songmao Zheng, Yan Li, Peter Luo, Li Zhang, Hongyun Zhao

Get full text